🔎 Trials Near Me

Domov › Rak prostate › Colorado

Klinične študije za Rak prostate v Colorado

40 študij za Rak prostate išče udeležence na lokacijah v Colorado.

Mesta v Colorado

Uradno besedilo študije (angleško)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Rocky Mountain Cancer Center, Denver
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Rocky Mountain Regional VA Medical Center, Aurora
  • Kaiser Permanente-Franklin, Denver
  • Shaw Cancer Center, Edwards
  • in še 3
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • UCHealth University of Colorado Hospital, Aurora
  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT07200830

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Sarah Cannon Research Institute at HealthOne, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Rocky Mountain Regional VA Medical Center, Aurora
  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • in še 15
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • UCHealth Memorial Hospital Central, Colorado Springs
  • Memorial Hospital North, Colorado Springs
  • Poudre Valley Hospital, Fort Collins
  • in še 3
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06632977

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • University of Colorado Anschutz Medical Campus, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Moški · Posodobljeno 28. sep. 2026 · NCT06095089

DESTINY-PANTUMOUR04

  • Research Site, Boulder
Vključevanje udeležencevOpazovalna študija
Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
  • Sarah Cannon Research Institute 1, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Moški · Posodobljeno 25. sep. 2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • University of Colorado Anschutz Medical Campus ( Site 0046), Aurora
  • UCHealth Highlands Ranch Hospital ( Site 0111), Highlands Ranch
  • Colorado Clinical Research ( Site 0067), Lakewood
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • AdventHealth Medical Group Urology of Denver, Denver
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 24. sep. 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Rocky Mountain Cancer Centers, Denver
Vključevanje udeležencevFaza 2/3
Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Denver
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 22. sep. 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Rocky Mountain Cancer Centers, Denver
Vključevanje udeležencevFaza 3
Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Lakewood
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 18. sep. 2026 · NCT06952803

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  • GSK Investigational Site, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Moški · Posodobljeno 18. sep. 2026 · NCT06990880

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053), Aurora
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT06925737

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

  • Colorado Clinical Research, Lakewood
  • Urology Associates, Littleton
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 15. sep. 2026 · NCT07332000

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Denver
  • United States Oncology Regulatory Affairs Corporate Office, Denver
  • US Oncology Research Investigational Products Center, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Moški · Posodobljeno 15. sep. 2026 · NCT07493512

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • UCHealth University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • UCHealth Memorial Hospital Central, Colorado Springs
  • in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05946213

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Keefe Memorial Hospital, Cheyenne Wells
  • Kaiser Permanente-Franklin, Denver
  • Poudre Valley Hospital, Fort Collins
  • in še 5
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Sarah Cannon Research Institute - Denver DDU, Denver
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06582017

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Aurora
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 26. avg. 2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 24. avg. 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Rocky Mountain Cancer Centers, Aurora
Vključevanje udeležencevFaza 1
Starost 18 in več · Moški · Posodobljeno 21. avg. 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • University of Colorado Health, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Moški · Posodobljeno 20. avg. 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • Saint Francis Cancer Center, Colorado Springs
  • in še 6
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 19. avg. 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Colorado, Aurora
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • UCHealth University of Colorado Hospital, Aurora
  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • in še 18
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 14. jul. 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Rocky Mountain Cancer Center, Colorado Springs
Vključevanje udeležencevFaza 1
Starost 18 in več · Moški · Posodobljeno 9. jul. 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Advent Health, Greenwood Village
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • University of Colorado, Aurora
Vključevanje udeležencevFaza 4
Starost 18–100 · Moški · Posodobljeno 4. jun. 2026 · NCT05803941

Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients

  • Colorado Research Center, Aurora
  • UCHealth-Southern Colorado, Colorado Springs
  • UCHealth-Metro Denver, Denver
  • in še 1
Vključevanje udeležencevZgodnja faza 1
Starost 18 in več · Moški · Posodobljeno 2. jun. 2026 · NCT05515978

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Denver
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06239194

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

  • University of Colorado Anschutz Medical Campus, Aurora
Vključevanje udeležencevFaza 2
Starost 18–89 · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT07001241

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Penrose-Saint Francis Healthcare, Colorado Springs
  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs
  • Saint Francis Cancer Center, Colorado Springs
  • in še 8
Vključevanje udeležencevFaza 2
Starost 18 in več · Moški · Posodobljeno 29. jan. 2026 · NCT05806515

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Aurora
  • Massive Bio SYNERGY-AI site, Denver
  • Massive Bio SYNERGY-AI site, Littleton
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Colorado Hospital, Aurora
  • Rocky Mountain Cancer Centers-Boulder, Boulder
  • UCHealth Memorial Hospital Central, Colorado Springs
  • in še 8
Vključevanje udeležencevFaza 3
Starost 18 in več · Moški · Posodobljeno 11. sep. 2025 · NCT03678025

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.